Search results
FDA reverses ban on Juul vape products, which remain on shelves
Washington Post· 22 hours agoThe decision will not immediately affect consumers — Juul products have remained on store shelves as...
FDA Rescinds Ban on Juul E-Cigarettes | FOX 28 Spokane
FOX 28 Spokane· 5 hours agoJuul was first banned from selling its vaping devices in the U.S. market back in June 2022, but the...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 hours agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Stock Split Watch: 3 Growth Stocks That Could Be Next
Motley Fool via Yahoo Finance· 1 hour agoRegeneron's other important product, the eye medication Eylea, should also perform well thanks to...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 2 days agoChatterjee and Wharton were speaking during a meeting of the FDA's Vaccines and Related Biological ...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 7 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company...
Juul e-cigarettes back under FDA review after marketing ban lifted By Proactive Investors
Investing.com· 23 hours agoThe US Food and Drug Administration (FDA) is rescinding an order that blocked the sale of Juul’s ...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 19 hours agoNovavax announced Thursday in an SEC filing that the FDA has set April 2025 as the deadline to take action to either fully approve or deny the company's...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 19 hours agoPfizer and Moderna are also planning...BioNTech and Moderna. But the Novavax Covid vaccine has never...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 4 days agoModerna CEO Stéphane Bancel stated: “The FDA approval of our second product, mRESVIA, builds on the strength and versatility of our mRNA platform....